October 30, 2024

WATCH: Behind the ECOG-ACRIN E1910 trial with lead investigator Dr. Mark Litzow

October 15, 2024

Cooperative groups develop consensus nomenclature for radiation targets on future lymphoma clinical trials

October 11, 2024

Journal of Clinical Oncology publishes RTOG 1106/ACRIN 6697 results: Midtreatment PET-adapted radiotherapy dose escalation fails to improve outcomes for lung cancer patients

October 11, 2024

Mid-treatment PET-adapted radiotherapy dose escalation fails to improve outcomes for lung cancer patients: Results of NRG-RTOG1106/ECOG-ACRIN 6697

September 10, 2024

Press Release: Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

August 21, 2024

How a patient’s role in a clinical trial for acute lymphocytic leukemia brought a cancer-free diagnosis, FDA approval

July 24, 2024

Press Release: New England Journal of Medicine publishes practice-changing E1910 trial results

June 14, 2024

E1910 trial leads to an FDA approval in B-cell acute lymphoblastic leukemia (B-ALL)

April 24, 2024

Press Release: ECOG-ACRIN research at ASCO 2024

ECOG-ACRIN Cancer Research Group